M06.80 classifies a form of rheumatoid arthritis that falls outside the specifically named RA subtypes (seronegative, Still's disease, rheumatoid bursitis, rheumatoid nodule) but without documentation of a specific anatomical site.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 16
- Region
- General
Documentation tips
What should appear in the chart to support M06.80.
Source · Editorial brief grounded in 6 cited references ↓
- Document the specific RA subtype or variant (e.g., seronegative but atypical presentation, overlap syndrome feature) that justifies M06.8x over M06.9 — without this, auditors have no basis for 'other specified.'
- Record the joint(s) involved by name and side so coders can move to a site-specific child code (M06.811–M06.89) rather than defaulting to the unspecified-site M06.80.
- Include serology results (RF titer, anti-CCP value) in every RA encounter note — a negative or indeterminate result directly informs whether M06 vs. M05 is appropriate.
- Document disease activity level and any functional status assessment tool administered (PROMIS PF10a, MDHAQ, HAQ-DI) to satisfy CMS MIPS Measure 178, which applies to M06.80.
- Note current DMARDs or biologics prescribed; this supports medical necessity for follow-up visits and downstream CPT coding for infusion or injection services.
Related CPT procedures
Procedure codes commonly billed with M06.80. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M06.80 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M06.80 when site is actually documented — if the note says 'bilateral wrists and knees,' use the site-specific child codes under M06.83x and M06.85x, not the unspecified-site code.
- Defaulting to M06.80 instead of M06.9 — M06.80 requires that the RA type be 'other specified'; if the note just says 'rheumatoid arthritis' with no further qualifier, M06.9 is correct.
- Confusing M06.80 with M06.09 — M06.09 is seronegative RA at multiple sites, a distinctly different axis (serological status vs. RA variant type); the two are not interchangeable.
- Missing the MIPS Measure 178 documentation requirement — M06.80 qualifies for the RA functional status denominator, and failing to record a functional status tool within 12 months affects quality scoring.
- Assigning M06.80 for juvenile patients — rheumatoid arthritis in patients under 16 belongs in M08 (juvenile arthritis); M06 codes are for adult-onset disease.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M06.80 sits under the M06.8 parent category for 'other specified rheumatoid arthritis' — meaning the clinician has identified a distinct RA subtype that doesn't map to seropositive RA (M05) or the other named M06 subcategories, but has not documented which joint or body region is affected. Use this code only when the RA variant is specified enough to rule out M06.9 (unspecified RA) but no site laterality is documented.
In practice, M06.80 is a fallback within its own subcategory — the 'unspecified site' sixth character. Site-specific codes like M06.811 (right shoulder), M06.821 (right elbow), or M06.831 (right wrist) should always be preferred when the physician documents laterality and joint involvement. CMS clinical guidance flags unspecified-site codes with an asterisk indicating that more specific codes should be considered first.
M06.80 is included in the CMS MIPS Quality Measure 178 denominator for RA functional status assessment, so encounters coded with it trigger the obligation to document a patient-reported functional status tool (e.g., PROMIS PF10a or MDHAQ) within 12 months. Failure to do so can affect quality performance scores.
Sibling codes
Other billable codes under M06.8 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01When should I use M06.80 instead of M06.9?
02Can M06.80 be used for seronegative RA?
03Which site-specific codes should I consider before landing on M06.80?
04Does M06.80 trigger any quality measure obligations?
05Is M06.80 appropriate for pediatric patients diagnosed with RA?
06How does M06.80 relate to seropositive RA codes under M05?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M06-/M06.80
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M06.80
- 04cms.govhttps://www.cms.gov/medicare/coding/icd10/downloads/icd10clinicalconceptsorthopedics1.pdf
- 05qpp.cms.govhttps://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2023_Measure_178_MIPSCQM.pdf
- 06pmc.ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7560310/
Mira AI Scribe
Mira AI Scribe captures the RA variant type the clinician names (e.g., 'other specified,' overlap features, atypical seronegative presentation), the specific joints and laterality mentioned, serology values (RF, anti-CCP), and whether a functional status tool was administered this visit. That prevents a drop to the nonspecific M06.9, supports escalation to a site-specific M06.8x child code, and satisfies the MIPS 178 documentation requirement in the same encounter note.
See how Mira captures M06.80 documentation